Literature DB >> 11883641

Comparative inhibitory effects of different compounds on rat oatpl (slc21a1)- and Oatp2 (Slc21a5)-mediated transport.

Yoshihisa Shitara1, Daisuke Sugiyama, Hiroyuki Kusuhara, Yukio Kato, Takaaki Abe, Peter J Meier, Tomoo Itoh, Yuichi Sugiyama.   

Abstract

PURPOSE: The purpose of the present study is to examine the selectivity of various inhibitors towards the rat organic anion transporting polypeptides 1 (Oatp1: gene symbol Slc21a1) and 2 (Oatp2: Slc21a5).
METHODS: The inhibitory effects of 20 compounds on the Oatpl-mediated transport of estradiol 17beta-D-glucuronide and on the Oatp2-mediated transport of digoxin were examined in cDNA-transfected LLC-PK1cells.
RESULTS: Among the compounds examined in this study, nonsteroidal anti-inflammatory drugs, deoxycorticosterone. and quinidine preferentially inhibited Oatpl. whereas digoxin, quinine, and rifampicin preferentially inhibited Oatp2 at low concentrations. On the other hand, propionic acid, re-ketoglutarate and p-aminohippurate showed no inhibitory effects on either transporter up to a concentration of 1,000 microM. The Ki values of ibuprofen and quinidine were estimated to be 19 and 13 times lower for Oatpl compared with Oatp2, whereas the values for rifampicin, quinine, and digoxin were 13, 20, and 100< times lower for Oatp2 compared with Oatpl.
CONCLUSIONS: At low concentrations, some of the tested inhibitors exert selective inhibition of either Oatpl- or Oatp2-mediated substrate transport. These selective inhibitors may be used at appropriate concentrations to estimate the maximum contribution of Oatp1 or Oatp2 to the total substrate uptake into rat hepatocytes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11883641     DOI: 10.1023/a:1014264614637

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  30 in total

1.  Molecular characterization and functional regulation of a novel rat liver-specific organic anion transporter rlst-1.

Authors:  M Kakyo; M Unno; T Tokui; R Nakagomi; T Nishio; H Iwasashi; D Nakai; M Seki; M Suzuki; T Naitoh; S Matsuno; H Yawo; T Abe
Journal:  Gastroenterology       Date:  1999-10       Impact factor: 22.682

2.  Estradiol 17 beta-D-glucuronide is a high-affinity substrate for oatp organic anion transporter.

Authors:  N Kanai; R Lu; Y Bao; A W Wolkoff; M Vore; V L Schuster
Journal:  Am J Physiol       Date:  1996-02

3.  Efficient selection for high-expression transfectants with a novel eukaryotic vector.

Authors:  H Niwa; K Yamamura; J Miyazaki
Journal:  Gene       Date:  1991-12-15       Impact factor: 3.688

4.  Expression cloning of a rat liver Na(+)-independent organic anion transporter.

Authors:  E Jacquemin; B Hagenbuch; B Stieger; A W Wolkoff; P J Meier
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-04       Impact factor: 11.205

5.  A pharmacokinetic analysis program (multi) for microcomputer.

Authors:  K Yamaoka; Y Tanigawara; T Nakagawa; T Uno
Journal:  J Pharmacobiodyn       Date:  1981-11

Review 6.  Recent advances in carrier-mediated hepatic uptake and biliary excretion of xenobiotics.

Authors:  M Yamazaki; H Suzuki; Y Sugiyama
Journal:  Pharm Res       Date:  1996-04       Impact factor: 4.200

7.  Carrier-mediated active transport of the glucuronide and sulfate of 6-hydroxy-5,7-dimethyl-2-methylamino-4-(3-pyridylmethyl) benzothiazole (E3040) into rat liver: quantitative comparison of permeability in isolated hepatocytes, perfused liver and liver in vivo.

Authors:  O Takenaka; T Horie; H Suzuki; Y Sugiyama
Journal:  J Pharmacol Exp Ther       Date:  1997-02       Impact factor: 4.030

8.  A novel human hepatic organic anion transporting polypeptide (OATP2). Identification of a liver-specific human organic anion transporting polypeptide and identification of rat and human hydroxymethylglutaryl-CoA reductase inhibitor transporters.

Authors:  B Hsiang; Y Zhu; Z Wang; Y Wu; V Sasseville; W P Yang; T G Kirchgessner
Journal:  J Biol Chem       Date:  1999-12-24       Impact factor: 5.157

9.  Rifamycin SV and rifampicin exhibit differential inhibition of the hepatic rat organic anion transporting polypeptides, Oatp1 and Oatp2.

Authors:  K Fattinger; V Cattori; B Hagenbuch; P J Meier; B Stieger
Journal:  Hepatology       Date:  2000-07       Impact factor: 17.425

10.  Transport of temocaprilat into rat hepatocytes: role of organic anion transporting polypeptide.

Authors:  H Ishizuka; K Konno; H Naganuma; K Nishimura; H Kouzuki; H Suzuki; B Stieger; P J Meier; Y Sugiyama
Journal:  J Pharmacol Exp Ther       Date:  1998-10       Impact factor: 4.030

View more
  17 in total

1.  Ibuprofen is a non-competitive inhibitor of the peptide transporter hPEPT1 (SLC15A1): possible interactions between hPEPT1 substrates and ibuprofen.

Authors:  Diana Højmark Omkvist; Birger Brodin; Carsten Uhd Nielsen
Journal:  Br J Pharmacol       Date:  2010-12       Impact factor: 8.739

Review 2.  Genetics or environment in drug transport: the case of organic anion transporting polypeptides and adverse drug reactions.

Authors:  John D Clarke; Nathan J Cherrington
Journal:  Expert Opin Drug Metab Toxicol       Date:  2012-01-27       Impact factor: 4.481

3.  Pharmacokinetics and response to pravastatin in paediatric patients with familial hypercholesterolaemia and in paediatric cardiac transplant recipients in relation to polymorphisms of the SLCO1B1 and ABCB1 genes.

Authors:  Mia Hedman; Marjatta Antikainen; Christer Holmberg; Mikko Neuvonen; Michel Eichelbaum; Kari T Kivistö; Pertti J Neuvonen; Mikko Niemi
Journal:  Br J Clin Pharmacol       Date:  2006-06       Impact factor: 4.335

4.  Hepatic disposition of ximelagatran and its metabolites in pig; prediction of the impact of membrane transporters through a simple disposition model.

Authors:  Erik Sjögren; Ulf Bredberg; Erik Allard; Björn Arvidsson; Jonas Bergquist; Tommy B Andersson; Hans Lennernäs
Journal:  Pharm Res       Date:  2010-02-06       Impact factor: 4.200

5.  Interaction between topically and systemically coadministered P-glycoprotein substrates/inhibitors: effect on vitreal kinetics.

Authors:  Ketan Hippalgaonkar; Ramesh Srirangam; Bharathi Avula; Ikhlas A Khan; Soumyajit Majumdar
Journal:  Drug Metab Dispos       Date:  2010-07-01       Impact factor: 3.922

6.  Cytochrome P450 mRNA expression in peripheral blood lymphocytes as a predictor of enzyme induction.

Authors:  Curtis E Haas; Daniel Brazeau; Denise Cloen; Brent M Booker; Valerie Frerichs; Colleen Zaranek; Reginald F Frye; Thomas Kufel
Journal:  Eur J Clin Pharmacol       Date:  2005-07-22       Impact factor: 2.953

7.  Role of the OATP Transporter Family and a Benzbromarone-SensitiveEfflux Transporter in the Hepatocellular Disposition of Vincristine.

Authors:  Johan Nicolaï; Louise Thevelin; Qi Bing; Bruno Stieger; Hugues Chanteux; Patrick Augustijns; Pieter Annaert
Journal:  Pharm Res       Date:  2017-08-21       Impact factor: 4.200

Review 8.  The drug transporter-metabolism alliance: uncovering and defining the interplay.

Authors:  Leslie Z Benet
Journal:  Mol Pharm       Date:  2009 Nov-Dec       Impact factor: 4.939

9.  Competitive inhibition of organic anion transporting polypeptide 1c1-mediated thyroxine transport by the fenamate class of nonsteroidal antiinflammatory drugs.

Authors:  Daniel E Westholm; David D Stenehjem; Jon N Rumbley; Lester R Drewes; Grant W Anderson
Journal:  Endocrinology       Date:  2008-10-09       Impact factor: 4.736

10.  Effect of albumin on the biliary clearance of compounds in sandwich-cultured rat hepatocytes.

Authors:  Kristina K Wolf; Kenneth R Brouwer; Gary M Pollack; Kim L R Brouwer
Journal:  Drug Metab Dispos       Date:  2008-07-24       Impact factor: 3.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.